Results

Total Results: 327 records

Showing results for "opiate".

141. Special K with no license to kill: accidental ketamine overdose on induction of general anesthesia. | PSNet
     psnet.ahrq.gov/issue/special-k-no-license-kill-accidental-ketamine-overdose-induction-general-anesthesia
     March 17, 2021 - Commentary Special K with no license to kill: accidental ketamine overdose on induction of general anesthesia. Citation Text: Warner LL, Smischney N. Accidental Ketamine Overdose on Induction of General Anesthesia. Am J Case Rep. 2018;19:10-12. Copy Citation Format: Google …

142. Prevention of fatal opioid overdose. | PSNet
     psnet.ahrq.gov/issue/prevention-fatal-opioid-overdose
     October 03, 2018 - Commentary Prevention of fatal opioid overdose. Citation Text: Beletsky L, Rich JD, Walley AY. Prevention of fatal opioid overdose. JAMA. 2012;308(18):1863-4. doi:10.1001/jama.2012.14205. Copy Citation Format: DOI Google Scholar PubMed BibTeX EndNote X3 XML EndNote 7 XML…

143. Subtherapeutic heparin infusions: is your organization at risk of bypassing soft low-dose alerts? | PSNet
     psnet.ahrq.gov/issue/subtherapeutic-heparin-infusions-your-organization-risk-bypassing-soft-low-dose-alerts
     November 18, 2020 - Newspaper/Magazine Article Subtherapeutic heparin infusions: is your organization at risk of bypassing soft low-dose alerts? Citation Text: ISMP Medication Safety Alert! Acute Care Edition. May 22, 2020;25(10). Copy Citation Save Save to your library Print …

144. FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. | PSNet
     psnet.ahrq.gov/issue/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label
     February 17, 2021 - Government Resource FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. Citation Text: Silver Spring, MD: US Food and Drug Administration; April 9, 2019. Copy Citation …

145. Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death. | PSNet
     psnet.ahrq.gov/issue/codeine-use-certain-children-after-tonsillectomy-andor-adenoidectomy-may-lead-rare-life
     September 01, 2021 - Government Resource Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death. Citation Text: MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; August 15, 2012. (Updated February 20, 2…

146. National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. | PSNet
     psnet.ahrq.gov/issue/national-trends-hospitalizations-opioid-poisonings-among-children-and-adolescents-1997-2012
     January 16, 2019 - Study National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. Citation Text: Gaither JR, Leventhal JM, Ryan SA, et al. National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012. JAMA Peds. 2016;1…

147. Strategies for flipping the script on opioid overprescribing. | PSNet
     psnet.ahrq.gov/issue/strategies-flipping-script-opioid-overprescribing
     May 29, 2019 - Commentary Strategies for flipping the script on opioid overprescribing. Citation Text: Wright AP, Becker WC, Schiff G. Strategies for Flipping the Script on Opioid Overprescribing. JAMA Intern Med. 2016;176(1):7-8. doi:10.1001/jamainternmed.2015.5946. Copy Citation Format: …

148. Opioids in Medicare Part D: Concerns About Extreme Use and Questionable Prescribing. | PSNet
     psnet.ahrq.gov/issue/opioids-medicare-part-d-concerns-about-extreme-use-and-questionable-prescribing
     October 29, 2008 - Book/Report Opioids in Medicare Part D: Concerns About Extreme Use and Questionable Prescribing. Citation Text: Office of the Inspector General. Washington, DC: US Department of Health and Human Services; July 2017. Report No. OEI-02-17-00250. Copy Citation Save S…

149. Reducing Adverse Drug Events Related to Opioids Implementation Guide. | PSNet
     psnet.ahrq.gov/issue/reducing-adverse-drug-events-related-opioids-implementation-guide
     April 22, 2009 - Book/Report Reducing Adverse Drug Events Related to Opioids Implementation Guide. Citation Text: Frederickson TW. Gordon DB, De Pinto M, et al. Philadelphia, PA: Society of Hospital Medicine; 2015. Copy Citation Save Save to your library Print Share …

150. Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review. | PSNet
     psnet.ahrq.gov/issue/automatable-algorithms-identify-nonmedical-opioid-use-using-electronic-data-systematic-review
     July 27, 2016 - Review Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review. Citation Text: Canan C, Polinski JM, Alexander C, et al. Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review. J Am Med Inform Assoc.…

151. Interventions for postsurgical opioid prescribing: a systematic review. | PSNet
     psnet.ahrq.gov/issue/interventions-postsurgical-opioid-prescribing-systematic-review
     May 05, 2010 - Review Emerging Classic Interventions for postsurgical opioid prescribing: a systematic review. Citation Text: Wick EC, Sehgal NL. A Learning Health System Approach to the Opioid Crisis. JAMA Surg. 2018;153(10):948-954. doi:10.1001/jamasurg.2018.2731. Copy Cit…

152. The effect of opioid prescribing guidelines on prescriptions by emergency physicians in Ohio. | PSNet
     psnet.ahrq.gov/issue/effect-opioid-prescribing-guidelines-prescriptions-emergency-physicians-ohio
     March 08, 2017 - Study The effect of opioid prescribing guidelines on prescriptions by emergency physicians in Ohio. Citation Text: Weiner SG, Baker O, Poon SJ, et al. The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio. Ann Emerg Med. 2017;70(6):799-808.e1. doi:1…

153. Prescription Drug Monitoring Programs: Evolution and Evidence. | PSNet
     psnet.ahrq.gov/issue/prescription-drug-monitoring-programs-evolution-and-evidence
     November 23, 2005 - Book/Report Prescription Drug Monitoring Programs: Evolution and Evidence. Citation Text: Weiner J, Bao Y, Meisel Z. LDI/CHERISH Issue Brief. June 2017. Copy Citation Save Save to your library Print Share Facebook Twitter Linkedin …

154. Spotlight Case July 2008 (ppt file)
     psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.296_slideshow.ppt
     April 01, 2013 - Spotlight Case July 2008 Spotlight Case Total Parenteral Nutrition, Multifarious Errors * * Source and Credits This presentation is based on the April 2013 AHRQ WebM&M Spotlight Case See the full article at http://webmm.ahrq.gov CME credit is available Commentary by: Joseph I. Boullata, PharmD, RPh, BCNSP…

155. Opioid abuse in chronic pain—misconceptions and mitigation strategies. | PSNet
     psnet.ahrq.gov/issue/opioid-abuse-chronic-pain-misconceptions-and-mitigation-strategies
     July 27, 2016 - Review Opioid abuse in chronic pain—misconceptions and mitigation strategies. Citation Text: Volkow ND, McLellan T. Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies. New Engl J Med. 2016;374(13):1253-1263. doi:10.1056/NEJMra1507771. Copy Citation Format: …

156. FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. | PSNet
     psnet.ahrq.gov/issue/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and
     January 25, 2017 - Government Resource FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. Citation Text: MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; January 11, 2018. …

157. The rate and costs attributable to intravenous patient-controlled analgesia errors. | PSNet
     psnet.ahrq.gov/issue/rate-and-costs-attributable-intravenous-patient-controlled-analgesia-errors
     March 05, 2008 - Study The rate and costs attributable to intravenous patient-controlled analgesia errors. Citation Text: Meissner B, Nelson W, Hicks R (R), et al. The rate and costs attributable to intravenous patient-controlled analgesia errors. Hosp Pharm. 2010;44(4):312-324. doi:10.1310/hpj4404-312. …

158. Findings of a naloxone database and its utilization to improve safety and education in a tertiary care medical center. | PSNet
     psnet.ahrq.gov/issue/findings-naloxone-database-and-its-utilization-improve-safety-and-education-tertiary-care
     April 12, 2023 - Study Findings of a naloxone database and its utilization to improve safety and education in a tertiary care medical center. Citation Text: Rosenfeld DM, Betcher JA, Shah RA, et al. Findings of a Naloxone Database and its Utilization to Improve Safety and Education in a Tertiary Care Med…

159. Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: a systematic review. | PSNet
     psnet.ahrq.gov/issue/strategies-identify-patient-risks-prescription-opioid-addiction-when-initiating-opioids-pain
     November 16, 2022 - Review Classic Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: a systematic review. Citation Text: Klimas J, Gorfinkel L, Fairbairn N, et al. Strategies to Identify Patient Risks of Prescription Opioid Addi…

160. Project Nurture Engages Pregnant People with Substance Use Disorder, Improves Maternal and Infant Outcomes. | PSNet
     psnet.ahrq.gov/innovation/project-nurture-engages-pregnant-people-substance-use-disorder-improves-maternal-and
     April 24, 2024 - Project Nurture Engages Pregnant People with Substance Use Disorder, Improves Maternal and Infant Outcomes. Save Save to your library Print Share Facebook Twitter Linkedin Copy URL March 11, 2021 Innovation Contact Inn…